{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:05:41Z","timestamp":1789088741953,"version":"build-2803163510"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T00:00:00Z","timestamp":1149724800000},"content-version":"vor","delay-in-days":5668,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Biochem. Toxicol."],"published-print":{"date-parts":[[1990,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cationic amphiphilic drugs induce a phospholipid storage disorder known as phospho\u2010lipidosis. Halogenated analogs of the drugs are more potent inducers of phospholipidosis when compared to nonhalogenated analogs. Two such antipsychotic drugs, promazine and chlorpromazine, are effectively taken up by the lungs and induce lamellar inclusions in vitro. We compared the in vivo toxicity and efficacy of promazine and chlorpromazine to induce phospholipidosis in the lung and in pulmonary alveolar macrophages. Male Sprague\u2010Dawley rats were given promazine or chlorpromazine (25 mg\/kg\/day, P.O., in water) for 5 weeks. Food intake was decreased in promazine\u2010 and chlorpromazine\u2010treated rats, chlorpromazine rats being affected more than promazine rats. To minimize experimental error due to starvation, control rats were pair\u2010fed. The body weight gain was decreased in chlorpromazine rats in comparison to pair\u2010fed controls. Chlorpromazine\u2010treated rats, but not promazine\u2010treated rats, showed increased mortality over the 5\u2010week treatment period. Histopathologic examination of lung revealed loss of alveolar macrophages with no other gross abnormalities in chlorpromazine\u2010treated rats. Quantitative analysis of lung lavage also showed significant reduction in the number of macrophages. This finding is in contrast to other cationic amphiphilic drugs, which induce phospholipidosis as well as accumulation of alveolar macrophages. Phospholipid level increased in alveolar macrophages but not in lavaged lung following chlorpromazine treatment. Acid phos\u2010phatase activity in lavaged lung homogenate and macrophages of promazine\u2010 and chlorpromazine\u2010treated rats,taken as an index of toxicity to cells, did not differ significantly from control rats. In vivo binding of promazine and chlorpromazine to the lamellar bodies isolated from lungs was quantitated using 1,6\u2010diphenyl\u20101,3,5\u2010hexatriene and 1\u2010anilino\u20108\u2010naphthalene sulfonate as fluorescence probes for hydrophobic and hydrophilic moieties, respectively. 1,6\u2010Diphenyl\u20101,3,5\u2010hexatriene or 1\u2010anilino\u20108\u2010naph\u2010thalene sulfonate fluorescence with lamellar bodies did not differ in control, promazine\u2010, or chlorpromazine\u2010treated rats, indicating that sufficient drug was not bound to lamellar bodies to be sensitive enough to detect using fluorescence probes. Thin\u2010layer chro\u2010matography identification of these drugs from lung extract revealed no detectable spots against the authentic drug standards indicating that promazine and chlorpromazine may not accumulate significantly in the lung in vivo to be detected by thin\u2010layer chromatography. These results indicate that chlorpromazine is more toxic to rats than promazine and decreases the alveolar macrophages, suggesting that macrophages are the targets of chlorpromazine\u2010in\u2010duced phospholipidosis. Long\u2010term chlorpromazine and promazine treatment may lead to phospholipidosis in alveolar macrophages, which can be a sensitive indicator of this disorder.<\/jats:p>","DOI":"10.1002\/jbt.2570050407","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T01:36:16Z","timestamp":1161135376000},"page":"245-251","source":"Crossref","is-referenced-by-count":17,"title":["In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats"],"prefix":"10.1002","volume":"5","author":[{"given":"Urmila P.","family":"Kodavanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia G.","family":"Lockard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harihara M.","family":"Mehendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602537408993738"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90435-5"},{"key":"e_1_2_1_4_2","first-page":"867","article-title":"Pulmonary sequestration of amiodarone and desethylamiodarone","volume":"237","author":"Camus Ph.","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_5_2","first-page":"91","article-title":"Drug\u2010induced pulmonary phospholipidosis","volume":"3","author":"Joshi U. M.","year":"1989","journal-title":"Comm. Toxicol."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(89)90078-7"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000137882"},{"key":"e_1_2_1_8_2","first-page":"150","article-title":"Types of interaction of amphiphilic drugs with phospholipid vesicles","volume":"246","author":"Joshi U. M.","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(70)90321-3"},{"key":"e_1_2_1_10_2","first-page":"442","article-title":"Uptake and accumulation of chlorpromazine in the isolated perfused rabbit lung","volume":"7","author":"Ohmiya Y.","year":"1979","journal-title":"Drug. Metab. Dispos."},{"key":"e_1_2_1_11_2","first-page":"116","article-title":"Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs","volume":"35","author":"Drenckhahn D.","year":"1976","journal-title":"Lab. Invest."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/10408447509164014"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00498258809055137"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb\/4.4.369"},{"key":"e_1_2_1_15_2","first-page":"55","article-title":"Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels","volume":"236","author":"Heyneman C. A.","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_16_2","first-page":"60","article-title":"Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro","volume":"236","author":"Heyneman C. A.","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-022X(82)90031-8"},{"key":"e_1_2_1_18_2","unstructured":"Sigma Technical Bulletin 104 (1981).The colorimetric determination of phosphatase. Sigma Chemical Company St. Louis MO."},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022029900005288"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_21_2","first-page":"199","volume-title":"Molecular Biology, Biochemistry and Biophysics 31: Membrane Spectroscopy","author":"Yguerabide J.","year":"1981"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(78)90412-8"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-2275(20)34331-5","article-title":"Fluorescence studies of the binding of amphiphilic amines with phospholipids","volume":"26","author":"Ma J. Y. C.","year":"1985","journal-title":"J. Lipid Res."},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(73)90072-2"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(82)90205-2"},{"key":"e_1_2_1_26_2","first-page":"283","article-title":"Hepatic injury associated with the phenothiazines","volume":"93","author":"Ishak K. G.","year":"1972","journal-title":"Arch. Pathol."},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(73)90087-2"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.344253"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000138232"},{"key":"e_1_2_1_30_2","first-page":"313","article-title":"Uptake and metabolism of chlorpromazine by rat and rabbit lungs","volume":"8","author":"Ohmiya Y.","year":"1980","journal-title":"Drug Metab. Dispos."}],"container-title":["Journal of Biochemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbt.2570050407","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.2570050407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:40:39Z","timestamp":1697996439000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbt.2570050407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["10.1002\/jbt.2570050407"],"URL":"https:\/\/doi.org\/10.1002\/jbt.2570050407","archive":["Portico"],"relation":{},"ISSN":["0887-2082","1522-7146"],"issn-type":[{"value":"0887-2082","type":"print"},{"value":"1522-7146","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,12]]}}}